Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Teva's $40.5B deal for Allergan generics arm reportedly close to EU approval
Teva's $40.5B deal for Allergan generics arm reportedly close to EU approval
Teva's $40.5B deal for Allergan generics arm reportedly close to EU approval
Submitted by
admin
on March 10, 2016 - 10:53am
Source:
BioPharma Dive
News Tags:
Teva Pharmaceutical
Allergan
generics
M&A
Europe
Headline:
Teva's $40.5B deal for Allergan generics arm reportedly close to EU approval
Do Not Allow Advertisers to Use My Personal information
